HIV Type 1 C and C′ Subclusters Based on Long Terminal Repeat Sequences in the Ethiopian HIV Type 1 Subtype C Epidemic

AIDS Research and Human Retroviruses

Volumn 19, Issue 10, 2003, Pages 917-922

  De Baar, Michel P ^a,b   Abebe, Almaz ^c   Kliphuis, Aletta ^a   Tesfaye, Girma ^d   Goudsmit, Jaap ^e   Pollakis, Georgios ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Primagen   (Netherlands)

^c ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^d National Blood Transfusion Service   (Ethiopia)

^e CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VIRUS RNA;

ENHANCER REGION; EPIDEMIC; ETHIOPIA; GENETIC VARIABILITY; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS TYPING;

BASE SEQUENCE; ETHIOPIA; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ALIGNMENT;

EID: 0242364669     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203322493094     Document Type: Review

References (19)

1. Hunt G and Tiemessen CT: Occurrence of additional NF-kappaB-binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates. AIDS Res Hum Retroviruses 2000;16:305-306.
2. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, and Berkhout B: Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 2000;74:3740-3751.
3. Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, and Essex M: Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 1997;71:8657-8665.
4. Chen BK, Feinberg MB, and Baltimore D: The kappaB sites in the human immunodeficiency, virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J Virol 1997;71:5495-5504.
5. Neilson JR, John GC, Carr JK, Lewis P, Kreiss JK, Jackson S, Nduati RW, Mbori-Ngacha D, Panteleeff DD, Bodrug S, Giachetti C, Bott MA, Richardson BA, Bwayo J, Ndinya-Achola J, and Overbaugh J: Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999;73:4393-4403.
6. Abebe A, Lukashov VV, Pollakis G, Kliphuis A, Fontanet AL, Goudsmit J, and de Wit TF: Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification. AIDS 2001;15:1555-1561.
7. Abebe A, Lukashov VV, Rinke De Wit TF, Fisseha B, Tegbaru B, Kliphuis A, Tesfaye G, Negassa H, Fontanet AL, Goudsmit J, and Pollakis G: Timing of the introduction into Ethiopia of subcluster C′ of HIV type 1 subtype C. AIDS Res Hum Retroviruses 2001; 17:657-661.
8. Aklilu M, Messele T, Tsegaye A, Biru T, Mariam DH, van Benthem B, Coutinho R, Rinke de Wit T, and Fontanet A: Factors associated with HIV-1 infection among sex workers of Addis Ababa, Ethiopia. AIDS 2001;15:87-96.
9. Mehret M, Mertens TE, Carael M, Negassa H, Feleke W, Yitbarek N, and Burton T: Baseline for the evaluation of an AIDS programme using prevention indicators: A case study in Ethiopia. Bull WHO 1996;74:509-516.
10. Fontanet AL, Messele T, Dejene A. Enquselassie F, Abebe A, Cutts FT, Rinke de Wit T, Sahlu T, Bindels P, Yeneneh H, Coutinho RA. and Nokes DJ: Age-and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia. AIDS 1998; 12:315-322.
11. Abebe A, Pollakis G, Fontanet AL, Fisseha B, Tegbaru, Kliphuis A, Tesfaye G, Negassa H, Cornelissen M, Goudsmit J, and Rinke De Wit TF: Identification of a genetic subcluster of HIV type 1 subtype C (C′) widespread in Ethiopia. AIDS Res Hum Retroviruses 2000;16:1909-1914.
12. de Baar MP, De Ronde A, Berkhout B, Cornelissen M, van der Horn KHM, van der Schoot AM, De Wolf F, Lukashov VV, and Goudsmit J: Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site. AIDS Res Hum Retroviruses 2000;16:499-504.
13. Choudhury S, Montano MA, Womack C, Blackard JT, Maniar JK, Saple DG, Tripathy S, Sahni S, Shah S, Babu GP, and Essex M: Increased promoter diversity reveals a complex phylogeny of human immunodeficiency virus type 1 subtype C in India. J Hum Virol 2000;3:35-43.
14. Scriba TJ, de Villiers T, Treurnicht FK, zur Megede J, Barnett SW, Engelbrecht S, and van Rensburg EJ: Characterization of the South African HIV type 1 subtype C complete 5′ long terminal repeat, nef, and regulatory genes. AIDS Res Hum Retroviruses 2002;18: 149-159.
15. Jubier-Maurin V, Saragosti S, Perret J-L, Mpoudi E, Esu-Williams E, Mulanga C, Liegeois F, Ekwalanga M, Delaporte E, and Peeters M: Genetic characterization of the nef gene from human immunodeficiency virus type 1 group M strains representing genetic subtypes A, B, C, E, F, G. and H. AIDS Res Hum Retroviruses 1999;15:23-32.
16. Rodenburg CM, Li Y, Trask SA, Chen Y, Decker J, Robertson DL, Kalish ML, Shaw GM, Allen S, Hahn BH, and Gao F: Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses 2001;17:161-168.
17. Pereira LA, Bentley K, Peeters A, Churchill MJ, and Deacon NJ: A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 2000;28:663-668.
18. Berkhout B, Ooms M, Beerens N, Huthoff H, Southern E, and Verhoef K: In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes. J Biol Chem 2002;277: 19967-19975.
19. de Baar MP, van Dooren MW, de Rooij E, Bakker M, Van Gemen B, Goudsmit J, and De Ronde A: Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from group M, N, and O. J Clin Microbiol 2000;39:1378-1384.